Oral Mucositis: Melatonin Gel an Effective New Treatment
AbstractThe current treatment for cervico-facial cancer involves radio and/or chemotherapy. Unfortunately, cancer therapies can lead to local and systemic complications such as mucositis, which is the most common dose-dependent complication in the oral cavity and gastrointestinal tract. Mucositis can cause a considerably reduced quality of life in cancer patients already suffering from physical and psychological exhaustion. However, the role of melatonin in the treatment of mucositis has recently been investigated, and offers an effective alternative therapy in the prevention and/or management of radio and/or chemotherapy-induced mucositis. This review focuses on the pathobiology and management of mucositis in order to improve the quality of cancer patients’ lives. View Full-Text
Share & Cite This Article
Abdel Moneim, A.E.; Guerra-Librero, A.; Florido, J.; Shen, Y.-Q.; Fernández-Gil, B.; Acuña-Castroviejo, D.; Escames, G. Oral Mucositis: Melatonin Gel an Effective New Treatment. Int. J. Mol. Sci. 2017, 18, 1003.
Abdel Moneim AE, Guerra-Librero A, Florido J, Shen Y-Q, Fernández-Gil B, Acuña-Castroviejo D, Escames G. Oral Mucositis: Melatonin Gel an Effective New Treatment. International Journal of Molecular Sciences. 2017; 18(5):1003.Chicago/Turabian Style
Abdel Moneim, Ahmed E.; Guerra-Librero, Ana; Florido, Javier; Shen, Ying-Qiang; Fernández-Gil, Beatriz; Acuña-Castroviejo, Darío; Escames, Germaine. 2017. "Oral Mucositis: Melatonin Gel an Effective New Treatment." Int. J. Mol. Sci. 18, no. 5: 1003.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.